Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study.
Biscarini S, Villa S, Genovese C, Tomasello M, Tonizzo A, Fava M, Iannotti N, Bolis M, Mariani B, Valzano AG, Morlacchi LC, Donato F, Castellano G, Cassin R, Carrabba M, Muscatello A, Gori A, Bandera A, Lombardi A. Biscarini S, et al. Among authors: cassin r. Biomedicines. 2022 Aug 18;10(8):2002. doi: 10.3390/biomedicines10082002. Biomedicines. 2022. PMID: 36009549 Free PMC article.
Reply to "successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients-A Czech multicenter experience": A case series of SARS-CoV-2 Omicron infection and aggressive lymphoma in the Sotrovimab era.
Cassin R, Rampi N, Anna Fidanza C, Muscatello A, Mariani B, Noto A, Rossi FG, Baldini L. Cassin R, et al. Hematol Oncol. 2023 Feb;41(1):213-217. doi: 10.1002/hon.3079. Epub 2022 Oct 3. Hematol Oncol. 2023. PMID: 36156809 Free PMC article.
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients.
Lombardi A, Viero G, Villa S, Biscarini S, Palomba E, Azzarà C, Iannotti N, Mariani B, Genovese C, Tomasello M, Tonizzo A, Fava M, Valzano AG, Morlacchi LC, Donato MF, Castellano G, Cassin R, Carrabba M, Muscatello A, Gori A, Bandera A. Lombardi A, et al. Among authors: cassin r. Biomedicines. 2023 May 26;11(6):1540. doi: 10.3390/biomedicines11061540. Biomedicines. 2023. PMID: 37371635 Free PMC article.
Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study.
Bucelli C, Fattizzo B, Cattaneo D, Giannotta JA, Barbullushi K, Pasquale R, Barozzi E, Barbanti MC, Pettine L, Rossi FG, Reda G, Cassin R, Barcellini W, Baldini L, Iurlo A. Bucelli C, et al. Among authors: cassin r. Front Oncol. 2021 Oct 18;11:701604. doi: 10.3389/fonc.2021.701604. eCollection 2021. Front Oncol. 2021. PMID: 34733777 Free PMC article.
Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients.
Fattizzo B, Bortolotti M, Rampi N, Cavallaro F, Giannotta JA, Bucelli C, Cassin R, Da Vià MC, Galassi G, Noto A, Pettine L, Rossi FG, Sciumè M, Ceriotti F, Consonni D, Barcellini W, Baldini L. Fattizzo B, et al. Among authors: cassin r. Front Immunol. 2022 May 12;13:852158. doi: 10.3389/fimmu.2022.852158. eCollection 2022. Front Immunol. 2022. PMID: 35634287 Free PMC article.
Ibrutinib in patients over 80 years old with CLL: a multicenter Italian cohort.
Reda G, Mattiello V, Frustaci AM, Visentin A, Mauro FR, Innocenti I, Gentile M, Giannarelli D, Noto A, Cassin R, Neri A, Laurenti L, Tedeschi A. Reda G, et al. Among authors: cassin r. Blood Adv. 2023 Feb 28;7(4):525-528. doi: 10.1182/bloodadvances.2022007619. Blood Adv. 2023. PMID: 35930765 Free PMC article. No abstract available.
Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia.
Reda G, Riva M, Fattizzo B, Cassin R, Giannarelli D, Pennisi M, Freyrie A, Cairoli R, Molteni A, Cortelezzi A. Reda G, et al. Among authors: cassin r. Semin Hematol. 2018 Oct;55(4):202-208. doi: 10.1053/j.seminhematol.2018.02.005. Epub 2018 Feb 21. Semin Hematol. 2018. PMID: 30502848 Review.
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy).
Fattizzo B, Giannotta JA, Barcellini W, Barbanti MC, Bucelli C, Cassin R, Cattaneo D, Cavallaro F, Ferla V, Fracchiolla NS, Freyrie A, Galassi G, Goldaniga MC, Grifoni FI, Iurlo A, Mangiameli G, Mattiello V, Meli M, Neri A, Noto A, Onida F, Ottani L, Pasquale R, Pettine L, Pompa A, Reda G, Rossi FG, Saporiti GN, Sciumè M, Tagliaferri E, Baldini L. Fattizzo B, et al. Among authors: cassin r. Blood Adv. 2020 Jul 14;4(13):2996-2999. doi: 10.1182/bloodadvances.2020002120. Blood Adv. 2020. PMID: 32609844 Free PMC article. No abstract available.
48 results